Clinical and epidemiological characterization of the Chikungunya epidemic in Paraguay



chikungunya, arbovirus, deaths, meningoencephalitis, notifications


During the summer of 2022 and 2023, the largest Chikungunya epidemic occurred in Paraguay, and one of the largest reported in the region. It was centralized in the metropolitan area of Asunción in a first stage, but it expanded to the rest of the country during the first months of 2023. This work has the objective of describing the epidemic epidemiologically and clinically from its beginning in epidemiological week 40 of 2022 to week 20 of 2023. Methodology: it is a descriptive study that uses the public data available on the page of the General Directorate of Health Surveillance. 86,761 cases were confirmed, 58% female, 8,227 hospital admissions, and 248 deaths. The global lethality is 2.8 per thousand confirmed cases. The most affected age groups correspond to the 0 to 4-year-old group (9%), however, the highest incidence of cases occurs in people over 80 years of age. The main challenges of this disease are the multidisciplinary approach in the management of the vector, the evaluation of the causes of this high lethality and the need for a vaccine for population use.


Download data is not yet available.


Cervantes-Acosta G, Sanjuán-Vergara H. Virus CHIKV: Características virales y evolución genética. Salud Uninorte. 2016;32(2):292-301. Recuperado de:

Her Z, Kam YW, Lin RT, Ng LF. CHIKV: a bending reality. Microbes Infect. 2009 Dec;11(14-15):1165-76. doi: 10.1016/j.micinf.2009.09.004.

Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika territory, in 1952-1953. Trans R Soc Trop Med Hyg. 1955 Jan;49(1):28-32. doi: 10.1016/0035-9203(55)90080-8.

Lumsden WH. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. II. General description and epidemiology. Trans R Soc Trop Med Hyg. 1955 Jan;49(1):33-57. doi: 10.1016/0035-9203(55)90081-x.

Sequera G. ¿Por qué esta gran epidemia de CHIKV? ¿Qué paso del dengue?. Un. fac. Cienc. Medicina. (Asunción). 2023 abril; 56(1): 19-24. Disponible en: .

Ministerio de Salud Pública y Bienestar Social. Sala de situaciones Arbovirus Situación Epidemiologica. Dirección General de Vigilancia de la Salud; 2023. Disponible en:

PAHO. Aumento de chikunguña en la Región de las Américas. Alerta Epidemiológica, PAHO, OMS; 2023.

MSPBS. Meningoencefalitis. 2022.

Brito CAA. Alert: Severe cases and deaths associated with Chikungunya in Brazil. Rev Soc Bras Med Trop. 2017 Sep;50(5):585-9. Available from:

Auerswald H, Boussioux C, In S, Mao S, Ong S, Huy R, et al. Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community. Emerg Microbes Infect. 2018;7(1):1-13. 10.1038/s41426-017-0010-0

Nitatpattana N, Kanjanopas K, Yoksan S, Satimai W, Vongba N, Langdatsuwan S, et al. Long-term persistence of Chikungunya virus neutralizing antibodies in human populations of North Eastern Thailand. Virol J. 2014 Oct 21;11:183. doi: 10.1186/1743-422X-11-183.

Franklinos LHV, Jones KE, Redding DW, Abubakar I. The effect of global change on mosquito-borne disease. Lancet Infect Dis. 2019 Sep;19(9):e302-e312. doi: 10.1016/S1473-3099(19)30161-6.

Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect Dis . 2007 May;7(5):306-7. doi: 10.1016/S1473



How to Cite

Benítez, I., Torales, M., Peralta, K., Dominguez, C., Grau, L., Sequera, G., & Morel, Z. (2023). Clinical and epidemiological characterization of the Chikungunya epidemic in Paraguay. Anales of the Faculty of Medical Sciences, 56(2), 18–26. Retrieved from